A clinical trial assessing the risks and benefits of puberty-blocking drugs in children who question their gender has been paused after safety concerns were raised by the UK medicines watchdog. The Medicines and Healthcare Products Regulatory Agency (MHRA) is set to hold talks with King's College London, whose researchers are …
This breakdown shows exactly how the Logic Quality and Community Trust scores were calculated, providing full transparency into our evaluation process.